MEDICAL NEWS TODAY: The boom in cancer biomarker investments over the past 25 years has not translated into major clinical success. READ MORE> The reasons for biomarker failures include problems with study design and interpretation, as well as statistical deficiencies, according to an article in The Journal of the National Cancer Institute. …if the biomarker [...]
Archive for the ‘Biomarkers’ Category
Reasons why biomarker cancer tests – like PSA – have their problems
Posted in Biomarkers, PSA tests, tagged benign prostatic hyperplasia, biomarker failures, cancer biomarkers, cancer research, catheter, Journal of the National Cancer Institute, MEDICAL NEWS TODAY, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate-specific antigen (PSA) biomarker, PSA, PSA test, statistical deficiencies on August 15, 2010 | Leave a Comment »
Prostate cancer genetic risks may be ‘population-specific’ rather than general
Posted in Biomarkers, PROSTATE CANCER, PROSTATE RESEARCH, PROSTATE RISKS, tagged bio-markers, cancer research, genetic risk factors, Japanese men, population-specific markers, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, risk variants, SCIENCE-CENTRIC.COM, Screening debate on September 5, 2009 | Leave a Comment »
SCIENCE-CENTRIC.COM: A study of prostate risk factors in Japanese men seems to reinforce the idea that discovered variants are often simply population-specific markers that need far more study to confirm as functional culprits.
PROSTATE MARKERS: Money wasted on genetic variations with little prognostic value
Posted in Biomarkers, Diagnosis, Genetic testing, PROSTATE CANCER, PROSTATE RESEARCH, tagged cancer research, genetic variations, Mike Scott, New Prostate Cancer Info-link, prognostic value, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate markers, prostate treatment debate on June 25, 2009 | Leave a Comment »
JUNE 25: NEW PROSTATE CANCER INFOLINK: “We need to start really focusing on whether this or that genetic variation has any prognostic impact on prostate cancer risk before we waste a lot of money chasing associations that have minimal likelihood of prognostic value,” writes Mike Scott.
PROSTATE DIAGNOSIS: Human genome project yields promising cancer tests beyond PSA
Posted in Biomarkers, Diagnosis, New tests, PROSTATE CANCER, PROSTATE RESEARCH, PSA tests, Screening debate, tagged beyond PSA, blood test, blood tests, cancer research, high throughput gene expression profiling, human genome project, molecular biomarkers, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer detection, prostate cancer treatments, prostate treatment, prostate treatment debate, prostate-specific antigen, PSA, PSA modifications, PSA test, Screening debate on June 21, 2009 | Leave a Comment »
JUNE 21: URO TODAY: The human genome project and high throughput gene expression profiling has recently yielded several promising molecular biomarkers for prostate cancer detection beyond PSA or PSA modifications.
PROSTATE TEST: Genetic fingerprint may help pinpoint men with cancer risk
Posted in Biomarkers, Diagnosis, Genetic testing, New tests, PROSTATE CANCER, PROSTATE RESEARCH, Screening debate, tagged blood test, blood tests, cancer research, prostablog, prostate, prostate blog, PROSTATE CANCER, Screening debate, unique genetic fingerprint on June 5, 2009 | Leave a Comment »
JUNE 6: WEB MD: A blood test that characterizes each prostate tumor by its unique genetic fingerprint may help pinpoint which men actually have prostate cancer, researchers say.









